Europe Digestive Health Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The european digestive health supplements market size in 2026 is estimated at USD 3.13 billion, growing from 2025 value of USD 2.95 billion with 2031 projections showing USD 4.21 billion, growing at 6.09% CAGR over 2026-2031. This report is Segmented by Type (Prebiotics, Probiotics, Enzymes, Botanicals, and Others), Form (Capsules and Softgels, Tablets, Gummies and Chewables, Powders and Granules, and Others), Distribution Channel (Supermarkets/Hypermarkets, Specialty and Health Stores, and More), and Geography (United Kingdom, Germany, France, and More). The Market Forecasts are Provided in Terms of Value (USD).

Europe Digestive Health Supplements Market Trends and Insights

Rising prevalence of IBS and functional GI disorders across Western Europe

The European digestive health supplements market is experiencing growth, driven by the prevalence of irritable bowel syndrome in 10-20% of the population. Women, who show higher IBS rates than men, are actively seeking alternatives to conventional medications for symptom relief. This trend mirrors broader supplement usage patterns, where women make up 57% of German supplement consumers compared to 45% of men. Healthcare systems across Europe have noted the rising economic burden of inflammatory bowel disease and gastrointestinal disorders, prompting patients to adopt preventive supplement strategies. With strong clinical evidence, clear demographic trends, and improved digital access, IBS management continues to fuel the expansion of the digestive health supplements market in Europe. Tech-savvy European consumers are increasingly drawn to digital health platforms that offer personalized symptom tracking and tailored supplement recommendations. This blend of clinical insights, shifting demographics, and digital advancements underscores the rising prominence of IBS management in propelling growth within Europe's digestive health supplements market.

Ageing population in Europe boosting demand for digestive enzymes

Pancreatic enzyme production decreases with age, affecting protein digestion. European research demonstrates reduced amino acid absorption after meals in older adults. This age-related change increases the demand for enzyme combinations that support nutrient breakdown. The connection between gut health and muscle maintenance encourages older consumers to use enzyme and probiotic combinations. As we age, our gut microbiome experiences significant shifts. Beneficial bacteria, such as Faecalibacterium and Lachnospiraceae, see a decline, while potentially harmful species become more prevalent. This shift has sparked heightened interest in prebiotic and probiotic interventions, as highlighted in Nutrients. Studies on centenarians indicate that a healthy aging process is linked to distinct microbiota profiles. Notably, these profiles showcase increased levels of Akkermansia and Butyricimonas. This correlation hints that tailored probiotic formulations might bolster longevity, a sentiment echoed in Current Gastroenterology Reports. Furthermore, the emerging understanding of the gut-muscle connection has spurred innovations in fermented solutions, aiming to enhance both digestive health and muscle upkeep. FrieslandCampina Ingredients responded to this trend by introducing a fermented gut-muscle product in 2024. These demographic factors contribute to the growth of the European digestive health supplements market.

EFSA's low health-claim approval rate for probiotics restricting on-pack claims

The European probiotics market faces significant regulatory challenges, as the European Food Safety Authority (EFSA) continues to enforce rigorous evaluation standards for health claims. Companies operating in this space must adapt to a complex regulatory environment where the term "probiotic" remains unauthorized under EU regulations, leading to diverse national interpretations. While the Czech Republic recognizes "probiotics" as a nutrition claim, France and Northern Ireland allow it as a general health claim, and Italy considers it outside health claim definitions altogether. This regulatory complexity has prompted the International Probiotics Association Europe to push for unified terminology standards, emphasizing the need for clear criteria in species characterization and safety documentation. The situation becomes more challenging with EFSA's upcoming novel food application guidelines in February 2025, which will require manufacturers to provide comprehensive safety data and detailed production information. These requirements not only increase compliance costs and development timelines but also create particular difficulties for smaller companies looking to introduce innovative products, especially in areas like personalized probiotics and new bacterial strains for digestive health.

Other drivers and restraints analyzed in the detailed report include:

• Integration of digestive supplements into daily nutritional regimens drives growth
• Enhanced digestive health awareness through digital media platforms adds to its growth
• Adulteration and potency degradation during supply-chain affecting brand trust

Segment Analysis

The European digestive health supplements market shows a clear consumer preference for probiotics, which currently command a 54.72% market share in 2025. This dominance stems from years of consumer trust in the effectiveness of bacterial strains, supported by extensive clinical studies validating their benefits for various gastrointestinal conditions.

In the evolving market landscape, enzyme supplements have emerged as the most dynamic segment, growing at an 8.32% CAGR from 2026-2031. This growth reflects the increasing needs of Europe's aging population, who often face challenges with pancreatic enzyme production and protein digestion. The market has also expanded to include younger consumers through specialized enzyme blends targeting lactose and gluten sensitivities. While prebiotics, botanicals, and innovative compounds such as magnesium L-threonate maintain their specific market positions, enzyme supplements are expected to deliver the highest incremental value to the European digestive health supplements market through 2031.

Complete Report Scope:

• By Type
  • Prebiotics
  • Probiotics
  • Enzymes
  • Botanicals
  • Others
• By Form
  • Capsules and Softgels
  • Tablets
  • Gummies and Chewables
  • Powders and Granules
  • Others
• By Distribution Channel
  • Supermarkets/Hypermarkets
  • Specialty and Health Stores
  • Online Retailers
  • Other Distribution Channels
• By Geography
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe

List of Companies Covered in this Report:

• Amway Corporation
• Bayer AG
• Herbalife Nutrition Ltd.
• BioGaia AB
• Symrise AG
• Optibac Probiotics
• Nestle S.A.
• Nature's Best
• Pinnacle Health Nutrition Limited
• ADM Protexin Ltd
• Lindens Health and Nutrition Limited
• Bulk
• Dr. med. Pleuse GmbH
• Dynveo SAS
• Dermapharm AG
• URGO SAS
• YAMAMOTO S.p.A
• STADA Arzneimittel AG
• Vitabiotics Ltd.
• Fairvital B.V.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support